AQST

Insider trade Sale by Barber Daniel (President and CEO)

15d ago

News Aquestive targets Q3 FDA resubmission for Anaphylm and projects >$150M cash at launch

19d ago

SEC filing AQST Appoints Thomas Zalewski Chief Legal Officer Compliance Officer Effective April 2 2026 100K RSUs 75K Options Inducement Grant

74d ago

Insider trade Sale by Sherry Korczynski (Chief Commercial Officer)

83d ago

Insider trade Sale by Ernest A Toth JR (Chief Financial Officer)

83d ago

Insider trade Sale by Melina Cioffi (SVP, Regulatory Affairs)

83d ago

Insider trade Sale by Lori J Braender (Chief Legal Officer)

83d ago

Insider trade Sale by Daniel Barber (President and CEO)

83d ago

Insider trade Sale by Peter E. Boyd (Chief People Officer)

83d ago

Insider trade Sale by Cassie Jung (Chief Operating Officer)

83d ago

News Aquestive Therapeutics GAAP EPS of -$0.26 misses by $0.13, revenue of $13M misses by $0.28M

89d ago

News INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST

138d ago

News Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update

144d ago